Regulus Therapeutics Inc. (RGLS)
Regulus Therapeutics Max Pain By Strike
RGLS trades at $8.16, 45.6% below the near-term max pain of $15 expiring Nov 21, 2025 (95 days). Look for upward drift as max pain acts as a magnet pulling price higher. Max pain is falling across expirations ($1-$15), signaling increased put positioning or downside protection. High dispersion in max pain levels suggests competing forces and potential volatility.
Regulus Therapeutics Max Pain By Expiry
Max pain for RGLS shows a downward trend from 15 to 1, indicating bearish sentiment or hedging activity. The 175% spread signals divergent expectations across timeframes. Levels distributed around 8.16. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Nov 21, 2025 | 15 | 6.84 (83.82%) |
| Jan 16, 2026 | 8 | -0.16 (-1.96%) |
| Feb 20, 2026 | 1 | -7.16 (-87.75%) |